s
Fermion’s TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA
05-02-2024, 14:10
– GUANGZHOU, China, Feb. 5, 2024 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain management, is pleased to announce the approval of the Investigational New Drug (IND) for its TYK2 JH2 inhibitor, FZ007-119, by the China National Medical Products […] L'articolo Fermion’s TYK2 JH2 Inhibitor FZ007-119 Granted IND Approval by China NMPA proviene da La Ragione.
CONTINUA A LEGGERE
17
0
0
Guarda anche
Libero Quotidiano
![Henlius Trastuzumab Receives FDA Approval in the United States](/img/static/get.php?image=https://www.liberoquotidiano.it/assets/images/placeholder_libero_gallery.png)
Henlius Trastuzumab Receives FDA Approval in the United States
Libero Quotidiano
![WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval](/img/static/get.php?image=https://www.liberoquotidiano.it/assets/images/placeholder_libero_gallery.png)
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
La Ragione
22:12
Le Pen: “La marea cresce, la nostra vittoria è solo rimandata”
La Ragione
19:43
Keys si fa male e si ritira, Paolini ai quarti di Wimbledon
La Ragione
19:34